RFG Advisory, LLC: DXJ position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of RFG Advisory, LLC on DXJ, newest first. How the timeline and the estimate are built.
RFG Advisory, LLC held 0 DXJ shares at 2025-12-31 per its 13F-HR filed 2026-02-03.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -5,234 shares
13F-HR 0001633387-26-000002 filed by RFG Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 5,234 sharesChange vs previous 13F +109 shares
0.01% of the 13F portfolio, value $670,099.
13F-HR 0001633387-25-000006 filed by RFG Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 5,125 sharesChange vs previous 13F +934 shares
0.01% of the 13F portfolio, value $585,616.
13F-HR 0001085146-25-004183 filed by RFG Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 4,191 sharesChange vs previous 13F -464 shares
0.01% of the 13F portfolio, value $461,719.
13F-HR 0001085146-25-001983 filed by RFG Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 4,655 sharesChange vs previous 13F -290 shares
0.01% of the 13F portfolio, value $513,357.
13F-HR 0001085146-25-000342 filed by RFG Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 4,945 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $524,150.
13F-HR 0001085146-24-004971 filed by RFG Advisory, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).